Moolec Science (MLEC) Liabilities and Shareholders Equity (2022 - 2026)

Moolec Science (MLEC) has 5 years of Liabilities and Shareholders Equity data on file, last reported at $104.2 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $104.2 million; the trailing twelve-month figure through Mar 2026 stood at $443.5 million (changed N/A YoY), and the FY2025 full-year result was $204.6 million, down 78.46% from the prior year.
• Liabilities and Shareholders Equity climbed to $104.2 million in Q1 2026, from $103.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $949.8 million in Q2 2024 to a low of $5.7 million in Q2 2022.
• A 5-year average of $119.7 million and a median of $26.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity jumped 3849.21% in 2024 and plunged 78.46% in 2025, its largest moves.
• Tracing MLEC's Liabilities and Shareholders Equity over 5 years: stood at $23.2 million in 2022, then dropped by 8.01% to $21.3 million in 2023, then surged by 47.19% to $31.4 million in 2024, then soared by 229.46% to $103.4 million in 2025, then increased by 0.78% to $104.2 million in 2026.
• Business Quant data shows MLEC's Liabilities and Shareholders Equity at $104.2 million in Q1 2026, $103.4 million in Q4 2025, and $204.6 million in Q2 2025.